ARTICLE | Company News
Response Genetics sales and marketing update
July 9, 2012 7:00 AM UTC
Response Genetics launched its EML4- ALK real-time PCR test to identify anaplastic lymphoma kinase (ALK) rearrangements in a sub-population of non-small cell lung cancer (NSCLC) patients who had nega...